Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
- PMID: 10433616
- DOI: 10.1093/jnci/91.15.1281
Anticancer agents targeting signaling molecules and cancer cell environment: challenges for drug development?
Comment in
-
Nontoxicity endpoints in phase I trial designs for targeted, non-cytotoxic agents.J Natl Cancer Inst. 2004 Jul 7;96(13):977-8. doi: 10.1093/jnci/djh208. J Natl Cancer Inst. 2004. PMID: 15240771 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
